EUSOI European Society of Ocular Inflammation

Membership

Joining the European Society of Ocular Inflammation (EUSOI) connects you with a focused community dedicated to improving the diagnosis, management and outcomes of patients with ocular inflammatory disease. As a member, you become part of a collaborative, multidisciplinary network that supports high-quality education, research and clinical excellence across Europe and beyond.

Who Can Become a Member

EUSOI welcomes all professionals with an interest in ocular inflammation and related systemic disease. Membership is open to clinicians, scientists and allied health professionals working in clinical care, research or education.

  • Ophthalmologists involved in the diagnosis and management of uveitis and other inflammatory eye diseases
  • Rheumatologists, immunologists and internists caring for patients with systemic inflammatory and autoimmune conditions affecting the eye
  • Other medical specialists whose practice involves ocular inflammatory manifestations
  • Basic, translational and clinical researchers with a focus on ocular immunology and inflammation
  • Allied health professionals, including nurses, optometrists, orthoptists and imaging specialists supporting care of patients with ocular inflammation
  • Trainees and early-career professionals who wish to develop expertise in this field

Membership Benefits

As a member of EUSOI, you gain access to a range of opportunities designed to support your professional development and enhance patient care.

  • Participation in scientific meetings, symposia and focused workshops on ocular inflammation
  • Access to educational activities and curated learning resources to support continuous professional development
  • Opportunities to collaborate on multicentre research projects and clinical studies
  • Networking with a pan-European community of clinicians, researchers and allied health professionals
  • Exposure to evolving standards of care, best practices and expert recommendations in ocular inflammation
  • Involvement in thematic working groups, task forces and committees contributing to the work of the Society
  • Dedicated initiatives and mentoring opportunities tailored for young and early-career members

Membership Categories

EUSOI offers several membership categories to reflect different stages of training, professional roles and geographical locations.

Full Member

For qualified medical specialists and researchers with an established focus on ocular inflammation or related systemic disease, who wish to contribute actively to the scientific and educational mission of the Society.

Trainee / Young Member

For residents, fellows, PhD candidates and early-career professionals who are developing their expertise in ocular inflammation and wish to engage with a supportive pan-European network.

Allied Health Professional

For nurses, optometrists, orthoptists, imaging specialists and other allied health professionals involved in the multidisciplinary care of patients with ocular inflammatory disease.

Associate / International Member

For professionals with an interest in ocular inflammation who are based outside the primary geographical focus of the Society, or who collaborate with EUSOI in research, education or clinical initiatives.

How to Join

Becoming a member of EUSOI is a simple process. Prospective members are invited to complete an online application form, providing brief information about their professional role, area of practice and interest in ocular inflammation.

Applications are reviewed and confirmed by the Society in line with its membership criteria. Once approved, new members receive confirmation of their status and information on how to access member activities and communications.

Stay Informed

To stay informed about EUSOI membership news, upcoming meetings, research initiatives and educational activities, we encourage you to register your interest and ensure your contact details are up to date. By joining our community, you will receive regular updates on opportunities to engage with colleagues and contribute to advancing care for patients with ocular inflammation.